| Group 1 (Amniotomy) | Group 2 (Oxytocin) | Group 3 (Amniotomy and Oxytocin) | Group 4 (Control) |  |
---|---|---|---|---|---|
Obstetric and demographic data | N = 21 | N = 20 | N = 16 | N = 23 | p |
Intra-partum fever | 3 (14) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.03 |
Antibiotics use | 3 (14) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.03 |
Epidural use | 12 (57) | 8 (40) | 7 (44) | 11 (48) | 0.7 |
Fetal scalp pH | 1 (5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.7 |
Vaginal examinations | 8.2 ± 3.5 (7)a | 6.4 ± 1.8 (6) | 5.1 ± 1.2 (5) | 6.7 ± 2.0 (7) | 0.009 |
Fetal Scalp electrode | 7(33) | 2 (10) | 4 (25) | 7 (30) | 0.3 |
Intra-uterine pressure catheter | 4 (19) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.008 |
Time from enrollment until delivery, min | 629 ± 338 (545)a | 590 ± 367 (444) | 420 ± 319 (363) | 740 ± 294 (689)a | 0.005 |
Duration of the first stage of labor, min | 555 ± 307 (506)a | 533 ± 359 (409)a | 351 ± 327 (253) | 651 ± 391 (580)a | 0.003 |
Time from enrollment until the beginning of the active phase, min | 339 ± 349 (298)a | 426 ± 372 (303)a | 206 ± 298 (105) | 435 ± 305 (370)a | 0.009 |
Duration of the active phase, min | 216 ± 161 (153) | 114 ± 54 (119)b | 139 ± 84 (140) | 205 ± 104 (178) | 0.01 |
Duration of the second stage, min | 75 ± 64 (51) | 57 ± 65 (32) | 69 ± 49 (50) | 89 ± 66 (86) | 0.4 |
Delivery mode | Â | Â | Â | Â | 0.5 |
Spontaneous vaginal | 16 (76) | 17 (85) | 14 (88) | 22 (96) | ---- |
Vacuum | 3 (14) | 2 (10) | 2 (13) | 1 (4) | --- |
Cesarean | 2 (10) | 1 (5) | 0 (0) | 0 (0) | 0.4 |
Vacuum or cesarean | 5 (24) | 3 (15) | 2 (13) | 1 (4) | 0.3 |
Early post partum hemorrhage | 0 (0.0) | 1 (5) | 0 (0.0) | 0 (0.0) | 0.5 |
Post-partum fever | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ---- |
Women satisfaction | 4.4 ± 0.9 (5) | 4.4 ± 0.7 (4)b | 4.8 ± 0.5 (5) | 5.0 ± 0.2 (5) | 0.002 |
Birthweight, gr | 3266 ± 487 (3334) | 3257 ± 297 (3314) | 3480 ± 385 (3428) | 3337 ± 424 (3298) | 0.4 |
Apgar score at 5 min | 10.0 ± 0.2 | 10.0 ± 0.2 | 9.9 ± 0.2 | 9.9 ± 0.4 | 1.0 |